Scolaris Content Display Scolaris Content Display

Daikenchuto para la reducción del íleo posoperatorio en los pacientes sometidos a una cirugía abdominal electiva

Esta versión no es la más reciente

Appendices

Appendix 1. CENTRAL search strategy

Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 6) in The Cochrane Library (searched 3 July 2017; 54 hits)
#1 (daikenchuto or dai‐kenchu‐to or dai‐ken‐chu‐to or DKT or TJ‐100 or TU‐100):ti,ab,kw

Appendix 2. MEDLINE search strategy

Ovid MEDLINE(R) Epub Ahead of Print, In‐Process & Other Non‐Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) (1946 to 3 July 2017; 230 hits)
1. (daikenchuto or dai‐kenchu‐to or dai‐ken‐chu‐to or DKT or TJ‐100 or TU‐100).mp

Appendix 3. Embase search strategy

Embase Ovid (1974 to 3 July 2017; 450 hits)
1. (daikenchuto or dai‐kenchu‐to or dai‐ken‐chu‐to or DKT or TJ‐100 or TU‐100).mp.

Appendix 4. ICHUSHI search strategy

Igaku Chuo Zasshi (ICHUSHI) (1977 to 3 July 2017; 1458 hits)
1. (daikenchuto or dai‐kenchu‐to or dai‐ken‐chu‐to or DKT or TJ‐100 or TU‐100).mp.

Appendix 5. Criteria for judging risk of bias in the 'Risk of bias' assessment tool

Random sequence generation: selection bias (biased allocation to interventions) due to inadequate generation of a randomized sequence

Criteria for a judgement of low risk of bias

The investigators describe a random component in the sequence generation process such as:

  • Referring to a random number table;

  • Using a computer random number generator;

  • Coin tossing;

  • Shuffling cards or envelopes;

  • Throwing dice;

  • Drawing of lots;

  • Minimisation*.

*Minimisation may be implemented without a random element, and this is considered to be equivalent to being random.

Criteria for a judgement of high risk of bias

The investigators describe a non‐random component in the sequence generation process. Usually, the description would involve some systematic, non‐random approach, for example:

  • Sequence generated by odd or even date of birth;

  • Sequence generated by some rule based on date (or day) of admission;

  • Sequence generated by some rule based on hospital or clinic record number.

Other non‐random approaches happen much less frequently than the systematic approaches mentioned above and tend to be obvious. They usually involve judgement, or some method of non‐random categorisation of participants, for example:

  • Allocation by judgement of the clinician;

  • Allocation by preference of the participant;

  • Allocation based on the results of a laboratory test or a series of tests;

  • Allocation by availability of the intervention.

Criteria for a judgement of unclear risk of bias

Insufficient information about the sequence generation process to permit judgement of low risk or high risk.

Allocation concealment: selection bias (biased allocation to intervention) due to inadequate concealment of allocations prior to assignment

Criteria for a judgement of low risk of bias

Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent method, was used to conceal allocation:

  • Central allocation (including telephone, web‐based and pharmacy‐controlled randomisation);

  • Sequentially‐numbered drug containers of identical appearance;

  • Sequentially‐numbered, opaque, sealed envelopes.

Criteria for a judgement of high risk of bias

Participants or investigators enrolling participants could possibly foresee assignment and thus introduce selection bias, such as allocation based on:

  • Using an open random allocation schedule (e.g. a list of random numbers);

  • Assignment envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non­opaque or not sequentially numbered);

  • Alternation or rotation;

  • Date of birth;

  • Case record number;

  • Any other explicitly unconcealed procedure.

Criteria for a judgement of unclear risk of bias

Insufficient information to permit judgement of low risk or high risk. This is usually the case if the method of concealment is not described or not described in sufficient detail to allow a definite judgement – for example if the use of assignment envelopes is described, but it remains unclear whether envelopes were sequentially‐numbered, opaque and sealed.

Blinding of participants and personnel: performance bias due to knowledge of the allocated interventions by participants and personnel during the study

Criteria for a judgement of low risk of bias

Any one of the following:

  • No blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced by lack of blinding;

  • Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.

Criteria for a judgement of high risk of bias

Any one of the following:

  • No blinding or incomplete blinding, and the outcome is likely to be influenced by lack of blinding;

  • Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken, and the outcome is likely to be influenced by lack of blinding.

Criteria for a judgement of unclear risk of bias

Any one of the following:

  • Insufficient information to permit judgement of low risk or high risk;

  • The study did not address this outcome.

Blinding of outcome assessment: detection bias due to knowledge of the allocated interventions by outcome assessors

Criteria for a judgement of low risk of bias

Any one of the following:

  • No blinding of outcome assessment, but the review authors judge that the outcome measurement is not likely to be influenced by lack of blinding;

  • Blinding of outcome assessment ensured, and unlikely that the blinding could have been broken.

Criteria for a judgement of high risk of bias

Any one of the following:

  • No blinding of outcome assessment, and the outcome measurement is likely to be influenced by lack of blinding;

  • Blinding of outcome assessment, but likely that the blinding could have been broken, and the outcome measurement is likely to be influenced by lack of blinding.

Criteria for a judgement of unclear risk of bias

Any one of the following:

  • Insufficient information to permit judgement of low risk or high risk;

  • The study did not address this outcome.

Incomplete outcome data: attrition bias due to amount, nature, or handling of incomplete data

Criteria for a judgement of low risk of bias

Any one of the following:

  • No missing outcome data;

  • Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias);

  • Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups;

  • For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a clinically‐relevant impact on the intervention effect estimate;

  • For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes not enough to have a clinically‐relevant impact on observed effect size;

  • Missing data have been imputed using appropriate methods.

Criteria for a judgement of high risk of bias

Any one of the following:

  • Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups;

  • For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinically‐relevant bias in intervention effect estimate;

  • For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes enough to induce clinically‐relevant bias in observed effect size;

  • 'As‐treated' analysis done with substantial departure of the intervention received from that assigned at randomisation;

  • Potentially inappropriate application of simple imputation.

Criteria for a judgement of unclear risk of bias

Any one of the following:

  • Insufficient reporting of attrition/exclusions to permit judgement of low risk or high risk (e.g. number randomised not stated, no reasons for missing data provided);

  • The study did not address this outcome.

Selective reporting: reporting bias due to selective outcome reporting

Criteria for a judgement of low risk of bias

Any of the following:

  • The study protocol is available and all of the study's pre‐specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre‐specified way;

  • The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre‐specified (convincing text of this nature may be uncommon).

Criteria for a judgement of high risk of bias

Any one of the following:

  • Not all of the study's pre‐specified primary outcomes have been reported;

  • One or more primary outcomes is reported using measurements, analysis methods, or subsets of the data (e.g. subscales) that were not pre‐specified;

  • One or more reported primary outcomes were not pre‐specified (unless clear justification for their reporting is provided, such as an unexpected adverse effect);

  • One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta‐analysis;

  • The study report fails to include results for a key outcome that would be expected to have been reported for such a study.

Criteria for a judgement of unclear risk of bias

Insufficient information to permit judgement of low risk or high risk. It is likely that the majority of studies will fall into this category.

Other bias: bias due to problems not covered elsewhere in the table

Criteria for a judgement of low risk of bias

The study appears to be free of other sources of bias.

Criteria for a judgement of high risk of bias

There is at least one important risk of bias. For example, the study:

  • Had a potential source of bias related to the specific study design used; or

  • Has been claimed to have been fraudulent; or

  • Has lack of blinding of data analysts or blinding of data analysts, but likely that the blinding could have been broken, and the outcome measurement is likely to be influenced by lack of blinding; or

  • Has some co‐intervention only in either group; or

  • Has baseline imbalance in participant characteristics, especially in age, sex, disease and its severity, surgical method, operative time and amount of intraoperative bleeding; or

  • Has an inadequate influence of funders due to industry‐initiated protocols; or

  • Has some other problem.

Criteria for a judgement of unclear risk of bias

There may be a risk of bias, but there is either:

  • Insufficient information to assess whether an important risk of bias exists; or

  • Insufficient rationale or evidence that an identified problem will introduce bias.

Study flow diagram
Figuras y tablas -
Figure 1

Study flow diagram

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies
Figuras y tablas -
Figure 2

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies

Risk of bias summary: review authors' judgements about each risk of bias item for each included study
Figuras y tablas -
Figure 3

Risk of bias summary: review authors' judgements about each risk of bias item for each included study

Trial Sequential Analysis for time from completion of operation to first bowel movement
Figuras y tablas -
Figure 4

Trial Sequential Analysis for time from completion of operation to first bowel movement

Comparison 1 Daikenchuto versus control, Outcome 1 Time from completion of operation to first flatus (hours).
Figuras y tablas -
Analysis 1.1

Comparison 1 Daikenchuto versus control, Outcome 1 Time from completion of operation to first flatus (hours).

Comparison 1 Daikenchuto versus control, Outcome 2 Time from completion of operation to first bowel movement (hours).
Figuras y tablas -
Analysis 1.2

Comparison 1 Daikenchuto versus control, Outcome 2 Time from completion of operation to first bowel movement (hours).

Comparison 1 Daikenchuto versus control, Outcome 3 Time from completion of operation to resumption of regular solid food intake (hours).
Figuras y tablas -
Analysis 1.3

Comparison 1 Daikenchuto versus control, Outcome 3 Time from completion of operation to resumption of regular solid food intake (hours).

Comparison 1 Daikenchuto versus control, Outcome 4 Any drug‐related adverse events.
Figuras y tablas -
Analysis 1.4

Comparison 1 Daikenchuto versus control, Outcome 4 Any drug‐related adverse events.

Comparison 1 Daikenchuto versus control, Outcome 5 Patient satisfaction.
Figuras y tablas -
Analysis 1.5

Comparison 1 Daikenchuto versus control, Outcome 5 Patient satisfaction.

Comparison 1 Daikenchuto versus control, Outcome 6 Incidence ratio of any re‐interventions before leaving hospital.
Figuras y tablas -
Analysis 1.6

Comparison 1 Daikenchuto versus control, Outcome 6 Incidence ratio of any re‐interventions before leaving hospital.

Comparison 1 Daikenchuto versus control, Outcome 7 Length of postoperative hospital stay (days).
Figuras y tablas -
Analysis 1.7

Comparison 1 Daikenchuto versus control, Outcome 7 Length of postoperative hospital stay (days).

Summary of findings for the main comparison. Daikenchuto compared to control for reducing postoperative ileus

Daikenchuto compared to control for reducing postoperative ileus

Participants: patients undergoing elective abdominal surgery, either open or laparoscopic

Setting: hospital

Intervention: all doses of Daikenchuto, administered orally and regularly in the preoperative or postoperative periods, or both

Comparison: placebo, any intestinal stimulant, or no treatment

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

№ of participants
(studies)

Certainty of the evidence
(GRADE)

Comments

Risk with control

Risk with Daikenchuto

Time from completion of operation to first flatus (hours)

The mean time from completion of operation to first flatus in the control groups was 75.50 hours

The mean time from completion of operation to first flatus in the Daikenchuto groups was 11.32 hours less
(17.45 hours less to 5.19 hours less)

83
(2 RCTs)

⊕⊝⊝⊝
VERY LOW 1 2

Time from completion of operation to first bowel movement (hours)

The mean time from completion of operation to first bowel movement in the control groups was 105.15 hours

The mean time from completion of operation to first bowel movement in the Daikenchuto groups was 9.44 hours less (22.22 hours less to 3.35 hours more)

500
(4 RCTs)

⊕⊝⊝⊝
VERY LOW 1 3 4

Time from completion of operation to resumption of regular solid food intake (hours)

The mean time from completion of operation to resumption of regular solid food intake in the control groups was 101.50 hours

The mean time from completion of operation to resumption of regular solid food intake in the Daikenchuto groups was 3.64 hours more
(24.45 hours less to 31.74 more)

258
(2 RCTs)

⊕⊝⊝⊝
VERY LOW 1 3 4

Any drug‐related adverse events (CTCAE grade ≥ 2)

Study population

RD 0.00 (‐0.02 to 0.02)

568
(5 RCTs)

⊕⊕⊝⊝
LOW 1 4

No events were reported in either arm in any of the studies

Patient satisfaction on day of discharge (Gastrointestinal Symptom Rating Scale (GSRS))

Range: a higher score represents greater satisfaction

The mean patient satisfaction in the control group on the day of discharge was 1.92

The mean patient satisfaction in the Daikenchuto group on the day of discharge was 0.09 points higher
(0.19 lower to 0.37 higher)

81
(1 RCT)

⊕⊝⊝⊝
VERY LOW 1 4

Incidence ratio of any re‐interventions before leaving hospital

Study population

RR 0.99
(0.06 to 15.62)

207
(1 RCT)

⊕⊕⊕⊝
MODERATE 4

10 per 1000

10 per 1000
(1 to 152)

Length of postoperative hospital stay (days)

The mean length of postoperative hospital stay for the control group was 17.37 days

The mean length of postoperative hospital stay for the Daikenchuto groups was 0.49 days lower
(1.21 days lower to 0.22 days higher)

292
(3 RCTs)

⊕⊕⊝⊝
LOW 1 4

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CI: confidence interval; CTCAE: Common Terminology Criteria for Adverse Events; RD: risk difference; RR: risk ratio; MD: mean difference

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 Downgraded by one level because of lack of blinding of participants, personnel, and outcome assessment

2 Downgraded by two levels because of a very small sample size

3 Downgraded by one level because of substantial heterogeneity

4 Downgraded by one level because of imprecision (95% confidence interval overlapped no effect)

Figuras y tablas -
Summary of findings for the main comparison. Daikenchuto compared to control for reducing postoperative ileus
Comparison 1. Daikenchuto versus control

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Time from completion of operation to first flatus (hours) Show forest plot

2

83

Mean Difference (IV, Fixed, 95% CI)

‐11.32 [‐17.45, ‐5.19]

2 Time from completion of operation to first bowel movement (hours) Show forest plot

4

500

Mean Difference (IV, Random, 95% CI)

‐9.44 [‐22.22, 3.35]

3 Time from completion of operation to resumption of regular solid food intake (hours) Show forest plot

2

258

Mean Difference (IV, Random, 95% CI)

3.64 [‐24.45, 31.74]

4 Any drug‐related adverse events Show forest plot

5

568

Risk Difference (M‐H, Fixed, 95% CI)

0.0 [‐0.02, 0.02]

5 Patient satisfaction Show forest plot

1

81

Mean Difference (IV, Fixed, 95% CI)

0.09 [‐0.19, 0.37]

6 Incidence ratio of any re‐interventions before leaving hospital Show forest plot

1

207

Risk Ratio (M‐H, Fixed, 95% CI)

0.99 [0.06, 15.62]

7 Length of postoperative hospital stay (days) Show forest plot

3

292

Mean Difference (IV, Fixed, 95% CI)

‐0.49 [‐1.21, 0.22]

Figuras y tablas -
Comparison 1. Daikenchuto versus control